Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FONR - US3444374058 - Common Stock

14.25 USD
-0.07 (-0.49%)
Last: 12/9/2025, 8:00:52 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FONR. FONR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While FONR has a great health rating, its profitability is only average at the moment. FONR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

FONR had positive earnings in the past year.
FONR had a positive operating cash flow in the past year.
In the past 5 years FONR has always been profitable.
FONR had a positive operating cash flow in each of the past 5 years.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.20%, FONR is in the better half of the industry, outperforming 77.54% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.00%, FONR is in the better half of the industry, outperforming 75.94% of the companies in the same industry.
The Return On Invested Capital of FONR (3.80%) is better than 72.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FONR is below the industry average of 8.81%.
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROIC 3.8%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

FONR has a better Profit Margin (6.63%) than 78.61% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.66%, FONR is in the better half of the industry, outperforming 77.54% of the companies in the same industry.
In the last couple of years the Operating Margin of FONR has declined.
FONR has a Gross Margin of 41.07%. This is in the lower half of the industry: FONR underperforms 66.84% of its industry peers.
FONR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

FONR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FONR has been reduced compared to 1 year ago.
The number of shares outstanding for FONR has been reduced compared to 5 years ago.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

FONR has an Altman-Z score of 2.76. This is not the best score and indicates that FONR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.76, FONR is doing good in the industry, outperforming 68.98% of the companies in the same industry.
The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.
FONR's Debt to FCF ratio of 0.05 is amongst the best of the industry. FONR outperforms 94.12% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that FONR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, FONR is doing good in the industry, outperforming 74.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 2.76
ROIC/WACC0.43
WACC8.78%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

A Current Ratio of 8.62 indicates that FONR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 8.62, FONR belongs to the best of the industry, outperforming 90.37% of the companies in the same industry.
A Quick Ratio of 8.46 indicates that FONR has no problem at all paying its short term obligations.
FONR has a Quick ratio of 8.46. This is amongst the best in the industry. FONR outperforms 90.37% of its industry peers.
Industry RankSector Rank
Current Ratio 8.62
Quick Ratio 8.46
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1

3. Growth

3.1 Past

FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.59%.
The Earnings Per Share has been growing slightly by 0.90% on average over the past years.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.36%.
FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.02% yearly.
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.70, the valuation of FONR can be described as correct.
88.24% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of FONR to the average of the S&P500 Index (26.29), we can say FONR is valued slightly cheaper.
Industry RankSector Rank
PE 13.7
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaper than 97.86% of the companies in the same industry.
FONR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FONR is cheaper than 94.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.09
EV/EBITDA 3.62
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)15.21
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FONR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FONAR CORP

NASDAQ:FONR (12/9/2025, 8:00:52 PM)

14.25

-0.07 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17 2025-11-17
Earnings (Next)02-16 2026-02-16
Inst Owners47.11%
Inst Owner Change-0.51%
Ins Owners4.39%
Ins Owner Change0%
Market Cap104.74M
Revenue(TTM)105.43M
Net Income(TTM)6.99M
Analysts0
Price TargetN/A
Short Float %0.37%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.7
Fwd PE N/A
P/S 0.99
P/FCF 14.09
P/OCF 9.27
P/B 0.6
P/tB 0.63
EV/EBITDA 3.62
EPS(TTM)1.04
EY7.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.01
FCFY7.1%
OCF(TTM)1.54
OCFY10.79%
SpS14.34
BVpS23.79
TBVpS22.77
PEG (NY)N/A
PEG (5Y)15.21
Graham Number23.6
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROCE 5.05%
ROIC 3.8%
ROICexc 5.21%
ROICexgc 5.49%
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
FCFM 7.05%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 101.91%
Cap/Sales 3.67%
Interest Coverage 547.62
Cash Conversion 80.82%
Profit Quality 106.36%
Current Ratio 8.62
Quick Ratio 8.46
Altman-Z 2.76
F-Score5
WACC8.78%
ROIC/WACC0.43
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.09%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-21.49%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%

FONAR CORP / FONR FAQ

Can you provide the ChartMill fundamental rating for FONAR CORP?

ChartMill assigns a fundamental rating of 5 / 10 to FONR.


Can you provide the valuation status for FONAR CORP?

ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.


Can you provide the profitability details for FONAR CORP?

FONAR CORP (FONR) has a profitability rating of 5 / 10.


How financially healthy is FONAR CORP?

The financial health rating of FONAR CORP (FONR) is 8 / 10.